[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:non-proliferative-diabetic-retinopathy":3},{"name":4,"total":5,"recruiting":5,"trials":6,"biomarkers":36,"states":37},"Non-Proliferative Diabetic Retinopathy",4,[7,15,22,29],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT07588100","A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of RO7663498 Following Intravitreal Administration in Participants With Diabetic Retinopathy",[11],"Phase 1","RECRUITING","2026-08-26T02:15:10.362237Z","2026-06-18T12:24:03.101565Z",{"nct_id":16,"title":17,"phases":18,"status":12,"updated_at":20,"content_modified":21},"NCT07235085","A Study to Evaluate the Efficacy and Safety of OTX-TKI (Axitinib Implant) in Participants With Non-Proliferative Diabetic Retinopathy",[19],"Phase 3","2026-08-26T02:17:05.997056Z","2026-05-05T02:43:28.735263Z",{"nct_id":23,"title":24,"phases":25,"status":12,"updated_at":27,"content_modified":28},"NCT07592273","Surabgene Lomparvovec Administered in the Suprachoroidal Space in Adult Participants With Diabetic Retinopathy Without Center-Involved Diabetic Macular Edema",[26],"Phase 2\u002FPhase 3","2026-08-26T02:18:43.501109Z","2026-05-29T15:36:40.202365Z",{"nct_id":30,"title":31,"phases":32,"status":12,"updated_at":34,"content_modified":35},"NCT07354477","Single-site Pilot Study Evaluating the Effect of QLS-111 Ophthalmic Solution on Posterior Perfusion and Vessel Dilation",[33],"Phase 2","2026-08-26T02:16:10.529598Z","2026-05-05T02:43:26.684329Z",[],[38],{"state":39,"count":40,"slug":41},"California",3,"california"]